Abstract 2880: Targeted drug therapies for osteosarcoma.

Leanne C. Sayles, Amanda Koehne, Kieren Marini, Alex G. Lee, Stanley G. Leung, Avanthi T. Shah, Marcus R. Breese, E. Alejandro Sweet-Cordero

Abstract 2880: Targeted drug therapies for osteosarcoma.

Leanne C. Sayles, Amanda Koehne, Kieren Marini, Alex G. Lee, Stanley G. Leung, Avanthi T. Shah, Marcus R. Breese, E. Alejandro Sweet-Cordero

Abstract 959: Proteomic and genetic interaction mapping of the Ras pathway reveals new effectors and vulnerabilities.

Marcus R. Kelly, Kyuho Han, Kaja Kostyrko, Edwin E. Jeng, Nancie Mooney, Alejandro Sweet-Cordero, Michael Bassik, Peter K. Jackson

Abstract 959: Proteomic and genetic interaction mapping of the Ras pathway reveals new effectors and vulnerabilities.

Marcus R. Kelly, Kyuho Han, Kaja Kostyrko, Edwin E. Jeng, Nancie Mooney, Alejandro Sweet-Cordero, Michael Bassik, Peter K. Jackson

Abstract 2880: Targeted drug therapies for osteosarcoma.

Leanne C. Sayles, Amanda Koehne, Kieren Marini, Alex G. Lee, Stanley G. Leung, Avanthi T. Shah, Marcus R. Breese, E. Alejandro Sweet-Cordero

Abstract 959: Proteomic and genetic interaction mapping of the Ras pathway reveals new effectors and vulnerabilities.

Marcus R. Kelly, Kyuho Han, Kaja Kostyrko, Edwin E. Jeng, Nancie Mooney, Alejandro Sweet-Cordero, Michael Bassik, Peter K. Jackson

Abstract PR05: Genomic analysis of osteosarcoma reveals opportunities for targeted therapy.

Leanne Sayles, Marcus Breese, Amanda Koehne, Krystal Straessler, Stanley Leung, Aviv Spillinger, Doug Hawkins, Steven Dubois, Alex Lee, Bogdan Tanasa, Kim Miok, Avanthi Shah, Sheri Spunt, Neyssa Marina, Kim Hazard, Alejandro Sweet-Cordero

Abstract PR05: Genomic analysis of osteosarcoma reveals opportunities for targeted therapy.

Leanne Sayles, Marcus Breese, Amanda Koehne, Krystal Straessler, Stanley Leung, Aviv Spillinger, Doug Hawkins, Steven Dubois, Alex Lee, Bogdan Tanasa, Kim Miok, Avanthi Shah, Sheri Spunt, Neyssa Marina, Kim Hazard, Alejandro Sweet-Cordero

Abstract PR12: A combined protein-protein interaction and genetic interaction map defines new and critical Kras effectors in non-small cell lung cancer.

Marcus R. Kelly, Kyuho Han, Nancie Mooney, Edwin Jeng, Kaja Kostyrko, Alejandro Sweet-Cordero, Michael Bassik, Peter K. Jackson

Abstract PR12: A combined protein-protein interaction and genetic interaction map defines new and critical Kras effectors in non-small cell lung cancer.

Marcus R. Kelly, Kyuho Han, Nancie Mooney, Edwin Jeng, Kaja Kostyrko, Alejandro Sweet-Cordero, Michael Bassik, Peter K. Jackson

Pages